Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06864884 · ClinicalTrials.gov registry record · Early Phase 1
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
A Early Phase 1 study of Acute Post Operative Pain and Third Molar Extraction Surgery, sponsored by Arcato Laboratories.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06864884 is a Early Phase 1 study of Acute Post Operative Pain and Third Molar Extraction Surgery that is actively recruiting participants, run by Arcato Laboratories. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06864884, a Early Phase 1 study of Acute Post Operative Pain and Third Molar Extraction Surgery, is actively recruiting participants, sponsored by Arcato Laboratories.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are: 1. How much of the investigational product is absorbed in the blood? 2. Are there side effects?
Conditions Studied
Interventions
- DRUG ARC-001
- DRUG Placebo gel
Study Locations (1)
Utah
- CenExel JBR - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-02-26 |
| Est. Completion | 2026-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06864884
The ClinicalTrials.gov registry entry for NCT06864884 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arcato Laboratories, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Post Operative Pain appearing as the primary indexed condition, and to 2 interventions - of which ARC-001 is the first listed.
NCT06864884 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT06864884 about?
NCT06864884 is a clinical study titled "A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction". The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are: 1. How much of the investigational product is absorbed in the blood? 2. Are there side ef...
What is the current status of trial NCT06864884?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2025-02-26. Estimated completion is 2026-02.
What conditions does trial NCT06864884 study?
This clinical trial studies the following conditions: Acute Post Operative Pain, Third Molar Extraction Surgery.
What interventions are being tested in trial NCT06864884?
The interventions under investigation include: ARC-001 (DRUG), Placebo gel (DRUG).
Who is sponsoring clinical trial NCT06864884?
This trial is sponsored by Arcato Laboratories, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06864884 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Post Operative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.